Caissa Capital Management ltd. - 31 May 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
31 May 2023
Net transactions value
+$2,422
Form type
4
Filing time
02 Jun 2023, 16:22:32 UTC
Previous filing
30 May 2023
Next filing
09 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $2,422 +844 +0.06% $2.87* 1,386,215 31 May 2023 See Footnote (1) F1
holding AVTX Common Stock 182,300 31 May 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 These shares are directly owned by Mr. Golestaneh in his personal capacity.